Literature DB >> 11344939

Steroid 11 beta-hydroxylase deficiency and related disorders.

P C White1.   

Abstract

Three disorders result from mutations involving two closely linked 11 beta-hydroxylase genes. Steroid 11 beta-hydroxylase deficiency results from mutations in CYP11B1. This is a form of congenital adrenal hyperplasia (CAH) characterized by hypertension and signs of androgen excess. Mutations in CYP11B2 cause aldosterone synthase deficiency, an isolated defect of aldosterone biosynthesis. Recombinations between these two genes cause glucocorticoid suppressible hyperaldosteronism, an autosomal dominant form of hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344939     DOI: 10.1016/s0889-8529(08)70019-7

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

Review 1.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

2.  Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.

Authors:  Vasantha Padmanabhan; Natalia R Salvetti; Valentina Matiller; Hugo H Ortega
Journal:  Endocrinology       Date:  2014-07-25       Impact factor: 4.736

Review 3.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

4.  Left ventricular failure due to a rare variant of congenital adrenal hyperplasia.

Authors:  Sonal Bhatia; Mamta N Muranjan; Keya R Lahiri
Journal:  Indian J Pediatr       Date:  2012-01-10       Impact factor: 1.967

5.  Hexaconazole exposure ravages biosynthesis pathway of steroid hormones: revealed by molecular dynamics and interaction.

Authors:  Sayed Aliul Hasan Abdi; Abdulaziz Alzahrani; Saleh Alghamdi; Ali Alquraini; Adel Alghamdi
Journal:  Toxicol Res (Camb)       Date:  2021-12-16       Impact factor: 3.524

6.  Detection of Small CYP11B1 Deletions and One Founder Chimeric CYP11B2/CYP11B1 Gene in 11β-Hydroxylase Deficiency.

Authors:  Hua Xie; Hui Yin; Xue Ye; Ying Liu; Na Liu; Yu Zhang; Xiaoli Chen; Xiaobo Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-24       Impact factor: 6.055

7.  Pediatric endocrine hypertension.

Authors:  Nisha Bhavani
Journal:  Indian J Endocrinol Metab       Date:  2011-10

8.  A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report.

Authors:  Xianxian Yuan; Lin Lu; Shi Chen; Jun Jiang; Xiangqing Wang; Zhihui Liu; Huijuan Zhu; Hui Pan; Zhaolin Lu
Journal:  BMC Endocr Disord       Date:  2018-09-21       Impact factor: 2.763

9.  Classical 11β-Hydroxylase Deficiency Caused by a Novel Homozygous Mutation: A Case Study and Literature Review.

Authors:  Mohammad N Alsanea; Abdulmoein Al-Agha; Mohamed Abdelmaksoud Shazly
Journal:  Cureus       Date:  2022-01-23

10.  Clinical and Genetic Characteristics of Patients with Corticosterone Methyloxidase Deficiency Type 2: Novel Mutations in CYP11B2

Authors:  Hande Turan; Aydilek Dağdeviren Çakır; Yavuz Özer; Gürkan Tarçın; Bahar Özcabi; Serdar Ceylaner; Oya Ercan; Saadet Olcay Evliyaoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.